Aug 9 (Reuters) - Sierra Oncology Inc SRRA.O :
* SIERRA ONCOLOGY REPORTS SECOND QUARTER RESULTS
* SIERRA ONCOLOGY INC - SRA737 + PARPI COMBINATION TRIAL EXPECTED TO BE INITIATED IN Q4 2018
* SIERRA ONCOLOGY INC - $125.4 MILLION CASH EXPECTED TO FUND PROGRAMS THROUGH APPROXIMATELY MID-2020
* SIERRA ONCOLOGY INC QTRLY LOSS PER SHARE $0.16